RAPT Therapeutics, Inc. (RAPT) Retained Earnings (2020 - 2024)
RAPT Therapeutics' Retained Earnings history spans 5 years, with the latest figure at $107000.0 for Q3 2024.
- For Q3 2024, Retained Earnings rose 100.02% year-over-year to $107000.0; the TTM value through Sep 2024 reached $107000.0, up 100.02%, while the annual FY2023 figure was $103000.0, 100.03% up from the prior year.
- Retained Earnings for Q3 2024 was $107000.0 at RAPT Therapeutics, up from -$542.9 million in the prior quarter.
- Across five years, Retained Earnings topped out at $339000.0 in Q1 2023 and bottomed at -$542.9 million in Q2 2024.
- The 5-year median for Retained Earnings is -$189000.0 (2021), against an average of -$130.3 million.
- The largest annual shift saw Retained Earnings plummeted 359717.57% in 2021 before it surged 130.35% in 2023.
- A 5-year view of Retained Earnings shows it stood at -$214.8 million in 2020, then crashed by 32.21% to -$284.0 million in 2021, then fell by 29.52% to -$367.9 million in 2022, then surged by 100.03% to $103000.0 in 2023, then rose by 3.88% to $107000.0 in 2024.
- Per Business Quant, the three most recent readings for RAPT's Retained Earnings are $107000.0 (Q3 2024), -$542.9 million (Q2 2024), and -$10000.0 (Q1 2024).